See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eurovision
Artificial Intelligence
Social Media
Soccer
Real Estate
Sanctions
Inflation
Donald Trump
Baseball
Vladimir Putin
NHS
Infrastructure
Published • loading... • Updated

SAGA Trial Results for Gildeuretinol Treating Geographic Atrophy with David Boyer, MD

Summary by hcplive.com
The recent trial indicates that the oral treatment gildeuretinol reduces GA lesion growth rates, as well as achieving better BCVA scores.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
hcplive.comhcplive.com

SAGA Trial Results for Gildeuretinol Treating Geographic Atrophy with David Boyer, MD

The recent trial indicates that the oral treatment gildeuretinol reduces GA lesion growth rates, as well as achieving better BCVA scores.

Read Full Article
ophthalmologytimes.comophthalmologytimes.com

Results of phase 2 clinical SAGA study of oral gildeuretinol for GA presented at ARVO 2025

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic atrophy linked to AMD.

Read Full Article
modernretina.commodernretina.com

Alkeus Pharmaceuticals presents additional data from Phase 2 clinical SAGA study for GA

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic atrophy linked to AMD.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

modernretina.com broke the news in on Thursday, May 8, 2025.
Sources are mostly out of (0)

Similar News Topics

News
For You
SearchBlindspotLocal